Oscar Health's profitability now faces headwinds from higher medical loss ratios and policy uncertainty. Read why OSCR stock ...

Bernstein has lowered its price target on UnitedHealth Group to $337 from $377 while keeping an ‘Outperform’ rating on the ...

DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...

UNH's oversold status has been overly done, as the market digests the market-wide headwinds arising from regulatory changes ...